Shionogi & Co., Ltd. (ADR)
General ticker "SGIOY" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $11.3B (TTM average)
Shionogi & Co., Ltd. (ADR) follows the US Stock Market performance with the rate: 27.1%.
Estimated limits based on current volatility of 1.5%: low 8.30$, high 8.55$
Factors to consider:
- Company pays dividends (irregularly): last record date 2025-09-30, amount 0.09$ (Y1.05%)
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-03-31 to 2027-03-31
- 2025-03-31 to 2026-03-31 estimated range: [5.81$, 9.23$]
- 2026-03-31 to 2027-03-31 estimated range: [5.87$, 9.35$]
Financial Metrics affecting the SGIOY estimates:
- Positive: with PPE of 12.5 at the end of fiscal year the price was very low
- Positive: Operating profit margin, % of 35.73 > 18.64
- Negative: negative Industry operating cash flow (median)
- Positive: Return on assets ratio (scaled to [-100,100]) of 9.99 > 6.04
- Negative: Operating cash flow per share per price, % of 5.02 <= 6.82
- Negative: 0.01 < Interest expense per share per price, % of 0.23
- Positive: Shareholder equity ratio, % of 88.70 > 63.39
Short-term SGIOY quotes
Long-term SGIOY plot with estimates
Financial data
| YTD | 2024-03-31 | 2025-03-31 |
|---|---|---|
| Operating Revenue | ¥435,081.00MM | ¥438,268.00MM |
| Operating Expenses | ¥281,771.00MM | ¥281,665.00MM |
| Operating Income | ¥153,310.00MM | ¥156,603.00MM |
| Non-Operating Income | ¥44,973.00MM | ¥44,147.00MM |
| Interest Expense | ¥6,701.00MM | ¥9,027.00MM |
| R&D Expense | ¥102,640.00MM | ¥108,612.00MM |
| Income(Loss) | ¥198,283.00MM | ¥200,750.00MM |
| Taxes | ¥37,708.00MM | ¥31,215.00MM |
| Profit(Loss)* | ¥162,030.00MM | ¥170,435.00MM |
| Stockholders Equity | ¥1,235,326.00MM | ¥1,361,924.00MM |
| Inventory | ¥64,916.00MM | ¥65,477.00MM |
| Assets | ¥1,416,918.00MM | ¥1,535,349.00MM |
| Operating Cash Flow | ¥154,284.00MM | ¥195,460.00MM |
| Capital expenditure | ¥28,267.00MM | ¥52,103.00MM |
| Investing Cash Flow | ¥5,922.00MM | ¥-116,080.00MM |
| Financing Cash Flow | ¥-126,853.00MM | ¥-64,908.00MM |
| Earnings Per Share** | ¥46.54 | ¥50.09 |
| Ordinary share to ADR | 4.00x | 4.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.